TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555 | -37.0% | 35,857 | -36.1% | 0.00% | -33.3% |
| Q2 2023 | $881 | -24.1% | 56,085 | -20.3% | 0.00% | -40.0% |
| Q1 2023 | $1,160 | +2.2% | 70,413 | -3.2% | 0.01% | +25.0% |
| Q4 2022 | $1,135 | -99.9% | 72,732 | -34.2% | 0.00% | -33.3% |
| Q3 2022 | $1,434,000 | -8.0% | 110,565 | -1.7% | 0.01% | -14.3% |
| Q2 2022 | $1,559,000 | +222.8% | 112,503 | +233.6% | 0.01% | +250.0% |
| Q1 2022 | $483,000 | +145.2% | 33,724 | +180.0% | 0.00% | +100.0% |
| Q3 2021 | $197,000 | – | 12,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |